To investigate whether the level of immune suppression in newly diagnosed HIV-associated KS patients affected the SARS-CoV-2 T cell responses, we categorized the study population into those with CD4 count above or below 200 cells/μl and compared the responses between these two subgroups. The gene discussed is CD4; the disease is Kaposi's sarcoma.